{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T20:40:27Z","timestamp":1792701627850,"version":"4.5.0"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T00:00:00Z","timestamp":1792627200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T00:00:00Z","timestamp":1792627200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"DOI":"10.1186\/s12872-026-06811-8","type":"journal-article","created":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T18:35:33Z","timestamp":1792694133000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Drug-coated balloons in coronary disease: meta-analysis comparing sirolimus- and paclitaxel-coated technologies"],"prefix":"10.1186","volume":"26","author":[{"given":"Mohammedrashid","family":"Ibraheem","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aly","family":"Abouslima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Ebrahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salma","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara E.","family":"Elbahnasawy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed Hesham","family":"Gamal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nada","family":"Ramadan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manar","family":"Adel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6872-7180","authenticated-orcid":false,"given":"Mahmoud M.","family":"Elhady","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,22]]},"reference":[{"issue":"2","key":"6811_CR1","doi-asserted-by":"publisher","first-page":"169","DOI":"10.2991\/jegh.k.201217.001","volume":"11","author":"U Ralapanawa","year":"2021","unstructured":"Ralapanawa U, Sivakanesan R. Epidemiology and the magnitude of coronary artery disease and acute coronary syndrome: a narrative review. J Epidemiol Glob Health. 2021;11(2):169\u201377.","journal-title":"J Epidemiol Glob Health"},{"issue":"7","key":"6811_CR2","first-page":"e46","volume":"121","author":"WG Members","year":"2010","unstructured":"Members WG, Lloyd-Jones D, Adams RJ, Brown TM, Carnethon M, Dai S, et al. Heart disease and stroke statistics\u20142010 update: a report from the American Heart Association. Circulation. 2010;121(7):e46\u2013215.","journal-title":"Circulation"},{"issue":"42","key":"6811_CR3","doi-asserted-by":"publisher","first-page":"2950","DOI":"10.1093\/eurheartj\/ehu299","volume":"35","author":"M Nichols","year":"2014","unstructured":"Nichols M, Townsend N, Scarborough P, Rayner M. Cardiovascular disease in Europe 2014: epidemiological update. Eur Heart J. 2014;35(42):2950\u20139.","journal-title":"Eur Heart J"},{"key":"6811_CR4","doi-asserted-by":"crossref","unstructured":"Alfonso F, Garc\u00eda-Guimaraes M. Optimal Coronary Interventions in Small Vessels. JACC Cardiovasc Interv [Internet]. 2016;9(13):1335\u20137. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1936879816305301","DOI":"10.1016\/j.jcin.2016.05.005"},{"key":"6811_CR5","doi-asserted-by":"crossref","unstructured":"Wybraniec MT, Ba\u0144ka P, Bochenek T, Roleder T, Mizia-Stec K. Small vessel coronary artery disease: How small can we go with myocardial revascularization? Cardiol J [Internet]. 2021;28(5):767\u201378. Available from: https:\/\/journals.viamedica.pl\/cardiology_journal\/article\/view\/68372","DOI":"10.5603\/CJ.a2020.0127"},{"key":"6811_CR6","unstructured":"Sim HW, Ananthakrishna R, Chan SP, Low AF, Lee CH, Chan MY et al. Treatment of Very Small De Novo Coronary Artery Disease With 2.0\u00a0mm Drug-Coated Balloons Showed 1-Year Clinical Outcome Comparable With 2.0\u00a0mm Drug-Eluting Stents. J Invasive Cardiol [Internet]. 2018;30(7):256\u201361. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/29656281"},{"key":"6811_CR7","doi-asserted-by":"crossref","unstructured":"Moreno R, Fern\u00e1ndez C, Alfonso F, Hern\u00e1ndez R, P\u00e9rez-Vizcayno MJ, Escaned J et al. Coronary stenting versus balloon angioplasty in small vessels. J Am Coll Cardiol [Internet]. 2004;43(11):1964\u201372. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S073510970400573X","DOI":"10.1016\/j.jacc.2004.01.039"},{"issue":"7398","key":"6811_CR8","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1136\/bmj.326.7398.1080","volume":"326","author":"ED Grech","year":"2003","unstructured":"Grech ED. Percutaneous coronary intervention. I: History and development. BMJ. 2003;326(7398):1080\u20132.","journal-title":"BMJ"},{"issue":"4","key":"6811_CR9","doi-asserted-by":"publisher","first-page":"33","DOI":"10.3390\/jpm8040033","volume":"8","author":"J Canfield","year":"2018","unstructured":"Canfield J, Totary-Jain H. 40 years of percutaneous coronary intervention: history and future directions. J Pers Med. 2018;8(4):33.","journal-title":"J Pers Med"},{"key":"6811_CR10","doi-asserted-by":"crossref","unstructured":"Duckers HJ, Nabel EG, Serruys PW. Essentials of restenosis. Springer; 2007.","DOI":"10.1007\/978-1-59745-001-0"},{"key":"6811_CR11","doi-asserted-by":"publisher","unstructured":"Rempakos A, Simsek B, Kostantinis S, Karacsonyi J, Choi JW, Poommipanit P et al. Impact of lesion length on the outcomes of chronic total occlusion percutaneous coronary intervention: Insights from the PROGRESS-CTO registry. Catheter Cardiovasc Interv [Internet]. 2023;101(4):747\u201355. Available from: https:\/\/onlinelibrary.wiley.com\/doi\/https:\/\/doi.org\/10.1002\/ccd.30581","DOI":"10.1002\/ccd.30581"},{"issue":"1","key":"6811_CR12","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1038\/nrcardio.2011.132","volume":"9","author":"JW Jukema","year":"2012","unstructured":"Jukema JW, Verschuren JJW, Ahmed TAN, Quax PHA. Restenosis after PCI. Part 1: pathophysiology and risk factors. Nat Rev Cardiol. 2012;9(1):53\u201362.","journal-title":"Nat Rev Cardiol"},{"issue":"2","key":"6811_CR13","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1080\/17482940701263285","volume":"9","author":"A Kibos","year":"2007","unstructured":"Kibos A, Campeanu A, Tintoiu I. Pathophysiology of coronary artery in-stent restenosis. Acute Card Care. 2007;9(2):111\u20139.","journal-title":"Acute Card Care"},{"issue":"2","key":"6811_CR14","doi-asserted-by":"publisher","first-page":"191","DOI":"10.2147\/vhrm.2007.3.2.191","volume":"3","author":"A Abizaid","year":"2007","unstructured":"Abizaid A. Sirolimus-eluting coronary stents: a review. Vasc Health Risk Manag. 2007;3(2):191\u2013201.","journal-title":"Vasc Health Risk Manag"},{"issue":"10","key":"6811_CR15","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1056\/NEJMoa067722","volume":"356","author":"B Lagerqvist","year":"2007","unstructured":"Lagerqvist B, James SK, Stenestrand U, Lindb\u00e4ck J, Nilsson T, Wallentin L. Long-term outcomes with drug-eluting stents versus bare-metal stents in Sweden. N Engl J Med. 2007;356(10):1009\u201319.","journal-title":"N Engl J Med"},{"issue":"6","key":"6811_CR16","doi-asserted-by":"publisher","first-page":"680","DOI":"10.4244\/EIJ-D-17-00494","volume":"13","author":"F Alfonso","year":"2017","unstructured":"Alfonso F, Scheller B. State of the art: balloon catheter technologies-drug-coated balloon. EuroIntervention. 2017;13(6):680\u201395.","journal-title":"EuroIntervention"},{"issue":"2","key":"6811_CR17","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1161\/CIRCULATIONAHA.113.001790","volume":"129","author":"F Otsuka","year":"2014","unstructured":"Otsuka F, Vorpahl M, Nakano M, Foerst J, Newell JB, Sakakura K, et al. Pathology of second-generation everolimus-eluting stents versus first-generation sirolimus-and paclitaxel-eluting stents in humans. Circulation. 2014;129(2):211\u201323.","journal-title":"Circulation"},{"issue":"7","key":"6811_CR18","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1016\/j.amjcard.2016.06.061","volume":"118","author":"JA Rymer","year":"2016","unstructured":"Rymer JA, Harrison RW, Dai D, Roe MT, Messenger JC, Anderson HV, et al. Trends in bare-metal stent use in the United States in patients aged\u2009\u2265\u200965 years (from the CathPCI Registry). Am J Cardiol. 2016;118(7):959\u201366.","journal-title":"Am J Cardiol"},{"issue":"6","key":"6811_CR19","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1159\/000547099","volume":"34","author":"A HaqAU, Suhail","year":"2025","unstructured":"HaqAU, Suhail A, Ahsan W, Maqbool H, Nawal A, Hassan H, et al. Efficacy of Drug Coated Balloon versus Drug Eluting Stent for Patients with De Novo Coronary Artery Disease: A Systematic Review and Meta-Analysis. Med Princ Pract. 2025;34(6):544\u201354. https:\/\/doi.org\/10.1159\/000547099","journal-title":"Med Princ Pract"},{"issue":"20","key":"6811_CR20","doi-asserted-by":"publisher","first-page":"2113","DOI":"10.1056\/NEJMoa061254","volume":"355","author":"B Scheller","year":"2006","unstructured":"Scheller B, Hehrlein C, Bocksch W, Rutsch W, Haghi D, Dietz U, et al. Treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter. N Engl J Med. 2006;355(20):2113\u201324.","journal-title":"N Engl J Med"},{"issue":"5","key":"6811_CR21","doi-asserted-by":"publisher","first-page":"176","DOI":"10.3390\/jcdd12050176","volume":"12","author":"M Marchetta","year":"2025","unstructured":"Marchetta M, Sasso S, Paragliola V, Maffi V, Chiricolo G, Massaro G, et al. Leaving Nothing Behind: Expanding the Clinical Frontiers of Drug-Coated Balloon Angioplasty in Coronary Artery Disease. J Cardiovasc Dev Dis. 2025;12(5):176.","journal-title":"J Cardiovasc Dev Dis"},{"issue":"21","key":"6811_CR22","doi-asserted-by":"publisher","first-page":"2664","DOI":"10.1016\/j.jacc.2020.04.006","volume":"75","author":"D Giacoppo","year":"2020","unstructured":"Giacoppo D, Alfonso F, Xu B, Claessen BEPM, Adriaenssens T, Jensen C, et al. Drug-coated balloon angioplasty versus drug-eluting stent implantation in patients with coronary stent restenosis. J Am Coll Cardiol. 2020;75(21):2664\u201378.","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"6811_CR23","first-page":"E317","volume":"92","author":"D Venetsanos","year":"2018","unstructured":"Venetsanos D, Lawesson SS, Panayi G, T\u00f6dt T, Berglund U, Swahn E, et al. Long-term efficacy of drug coated balloons compared with new generation drug\u2010eluting stents for the treatment of de novo coronary artery lesions. Catheter Cardiovasc Interv. 2018;92(5):E317\u201326.","journal-title":"Catheter Cardiovasc Interv"},{"issue":"7","key":"6811_CR24","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1161\/01.CIR.0000138929.71660.E0","volume":"110","author":"B Scheller","year":"2004","unstructured":"Scheller B, Speck U, Abramjuk C, Bernhardt U, B\u00f6hm M, Nickenig G. Paclitaxel balloon coating, a novel method for prevention and therapy of restenosis. Circulation. 2004;110(7):810\u20134.","journal-title":"Circulation"},{"issue":"4","key":"6811_CR25","doi-asserted-by":"publisher","first-page":"e003543","DOI":"10.1161\/CIRCINTERVENTIONS.115.003543","volume":"9","author":"YP Clever","year":"2016","unstructured":"Clever YP, Peters D, Calisse J, Bettink S, Berg MC, Sperling C, et al. Novel sirolimus\u2013coated balloon catheter: in vivo evaluation in a porcine coronary model. Circ Cardiovasc Interv. 2016;9(4):e003543.","journal-title":"Circ Cardiovasc Interv"},{"issue":"4","key":"6811_CR26","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1093\/ejcts\/ezu366","volume":"46","author":"AF members","year":"2014","unstructured":"members AF, Kolh P, Windecker S, Alfonso F, Collet JP, Cremer J, et al. 2014 ESC\/EACTS guidelines on myocardial revascularization: the Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) developed with the special contribution. Eur J cardio-thoracic Surg. 2014;46(4):517\u201392.","journal-title":"Eur J cardio-thoracic Surg"},{"issue":"12","key":"6811_CR27","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.4155\/fmc-2019-0304","volume":"12","author":"H Jinnouchi","year":"2020","unstructured":"Jinnouchi H, Guo L, Sakamoto A, Sato Y, Cornelissen A, Kawakami R, et al. Advances in mammalian target of rapamycin kinase inhibitors: application to devices used in the treatment of coronary artery disease. Future Med Chem. 2020;12(12):1181\u201395.","journal-title":"Future Med Chem"},{"issue":"6","key":"6811_CR28","first-page":"e307","volume":"21","author":"Y Zhou","year":"2025","unstructured":"Zhou Y, Hu Y, Zhao X, Chen Z, Li C, Ma L, et al. Sirolimus-coated versus paclitaxel-coated balloons for bifurcated coronary lesions in the side branch: the SPACIOUS trial. EuroIntervention J Eur Collab Work Gr Interv Cardiol Eur Soc Cardiol. 2025;21(6):e307\u201317.","journal-title":"EuroIntervention J Eur Collab Work Gr Interv Cardiol Eur Soc Cardiol"},{"issue":"9","key":"6811_CR29","doi-asserted-by":"publisher","first-page":"e014064","DOI":"10.1161\/CIRCINTERVENTIONS.124.014064","volume":"17","author":"W Wa\u0144ha","year":"2024","unstructured":"Wa\u0144ha W, Iwa\u0144czyk S, Januszek R, Wolny R, Tomasiewicz B, Kuliczkowski W, et al. Long-term outcomes following sirolimus-coated balloon or drug-eluting stents for treatment of in-stent restenosis. Circ Cardiovasc Interv. 2024;17(9):e014064.","journal-title":"Circ Cardiovasc Interv"},{"key":"6811_CR30","first-page":"852","volume-title":"Bench to bedside: the development of rapamycin and its application to stent restenosis","author":"SO Marx","year":"2001","unstructured":"Marx SO, Marks AR. Bench to bedside: the development of rapamycin and its application to stent restenosis. Volume 104. Circulation: Lippincott Williams & Wilkins; 2001. pp. 852\u20135."},{"issue":"4","key":"6811_CR31","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/j.cardiores.2004.04.029","volume":"63","author":"AJ Carter","year":"2004","unstructured":"Carter AJ, Aggarwal M, Kopia GA, Tio F, Tsao PS, Kolata R, et al. Long-term effects of polymer-based, slow-release, sirolimus-eluting stents in a porcine coronary model. Cardiovasc Res. 2004;63(4):617\u201324.","journal-title":"Cardiovasc Res"},{"key":"6811_CR32","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"PageMJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. https:\/\/doi.org\/10.1136\/bmj.n71","journal-title":"BMJ"},{"key":"6811_CR33","volume-title":"Cochrane handbook for systematic reviews of interventions","author":"J Chandler","year":"2019","unstructured":"Chandler J, Cumpston M, Li T, Page MJ, Welch V. Cochrane handbook for systematic reviews of interventions. Hoboken: Wiley; 2019."},{"key":"6811_CR34","doi-asserted-by":"publisher","unstructured":"Dai W, Yi Y, Lin A, Zhou C, Zhang J, Wang S et al. Onlinemeta: A Web Server for Meta-Analysis Based on Shiny Framework [Internet]. 2022. Available from: http:\/\/biorxiv.org\/lookup\/doi\/https:\/\/doi.org\/10.1101\/2022.04.13.488126","DOI":"10.1101\/2022.04.13.488126"},{"issue":"6","key":"6811_CR35","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/j.jcin.2018.11.040","volume":"12","author":"RM Ali","year":"2019","unstructured":"Ali RM, Abdul Kader MASK, Wan Ahmad WA, Ong TK, Liew HB, Omar AF, et al. Treatment of Coronary Drug-Eluting Stent Restenosis by a Sirolimus- or Paclitaxel-Coated Balloon. JACC Cardiovasc Interv. 2019;12(6):558\u201366.","journal-title":"JACC Cardiovasc Interv"},{"issue":"21","key":"6811_CR36","first-page":"e1322","volume":"20","author":"B Scheller","year":"2024","unstructured":"Scheller B, Mangner N, Jeger RV, Afan S, Mahfoud F, Woitek FJ, et al. A randomised trial of sirolimus- versus paclitaxel-coated balloons for de novo coronary lesions. EuroIntervention J Eur Collab Work Gr Interv Cardiol Eur Soc Cardiol. 2024;20(21):e1322\u20139.","journal-title":"EuroIntervention J Eur Collab Work Gr Interv Cardiol Eur Soc Cardiol"},{"issue":"9","key":"6811_CR37","doi-asserted-by":"publisher","first-page":"e012305","DOI":"10.1161\/CIRCINTERVENTIONS.122.012305","volume":"15","author":"B Scheller","year":"2022","unstructured":"Scheller B, Mangner N, Abdul Kader MASK, Wan Ahmad WA, Jeger R, W\u00f6hrle J, et al. Combined Analysis of Two Parallel Randomized Trials of Sirolimus-Coated and Paclitaxel-Coated Balloons in Coronary In-Stent Restenosis Lesions. Circ Cardiovasc Interv. 2022;15(9):e012305.","journal-title":"Circ Cardiovasc Interv"},{"issue":"5","key":"6811_CR38","doi-asserted-by":"publisher","first-page":"e014677","DOI":"10.1161\/CIRCINTERVENTIONS.124.014677","volume":"18","author":"L Pleva","year":"2025","unstructured":"Pleva L, Kukla P, Kovarnik T, Zapletalova J. Comparing the Efficacy of Sirolimus and Paclitaxel-Eluting Balloon Catheters in the Treatment of Coronary In-Stent Restenosis: A Prospective Randomized Study (TIS 2 Study). Circ Cardiovasc Interv. 2025;18(5):e014677.","journal-title":"Circ Cardiovasc Interv"},{"issue":"23","key":"6811_CR39","doi-asserted-by":"publisher","first-page":"2884","DOI":"10.1016\/j.jcin.2023.09.026","volume":"16","author":"K Ninomiya","year":"2023","unstructured":"Ninomiya K, Serruys PW, Colombo A, Reimers B, Basavarajaiah S, Sharif F, et al. A Prospective Randomized Trial Comparing Sirolimus-Coated Balloon With Paclitaxel-Coated Balloon in De Novo Small Vessels. JACC Cardiovasc Interv. 2023;16(23):2884\u201396.","journal-title":"JACC Cardiovasc Interv"},{"issue":"8","key":"6811_CR40","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1016\/j.jcin.2024.12.024","volume":"18","author":"H Liu","year":"2025","unstructured":"Liu H, Li Y, Fu G, An J, Chen S, Zhong Z, et al. Sirolimus- vs Paclitaxel-Coated Balloon for the Treatment of Coronary In-Stent Restenosis: The SIBLINT-ISR Randomized Trial. JACC Cardiovasc Interv. 2025;18(8):963\u201371.","journal-title":"JACC Cardiovasc Interv"},{"issue":"7","key":"6811_CR41","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1016\/j.jcin.2022.01.012","volume":"15","author":"WAW Ahmad","year":"2022","unstructured":"Ahmad WAW, Nuruddin AA, Abdul Kader MASK, Ong TK, Liew HB, Ali RM, et al. Treatment of Coronary De Novo Lesions by a Sirolimus- or Paclitaxel-Coated Balloon. JACC Cardiovasc Interv. 2022;15(7):770\u20139.","journal-title":"JACC Cardiovasc Interv"},{"issue":"14","key":"6811_CR42","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1016\/j.jacc.2007.06.047","volume":"50","author":"S Albert","year":"2007","unstructured":"Albert S, Alban D, Stephan W, Julinda M, Jos\u00e9 S, de Christoph L. A Meta-Analysis of 16 Randomized Trials of Sirolimus-Eluting Stents Versus Paclitaxel-Eluting Stents in Patients With Coronary Artery Disease. JACC. 2007;50(14):1373\u201380.","journal-title":"JACC"},{"issue":"4","key":"6811_CR43","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1016\/j.ahj.2007.11.021","volume":"155","author":"HS Gurm","year":"2008","unstructured":"Gurm HS, Boyden T, Welch KB. Comparative safety and efficacy of a sirolimus-eluting versus paclitaxel-eluting stent: a meta-analysis. Am Heart J. 2008;155(4):630\u20139.","journal-title":"Am Heart J"},{"issue":"3","key":"6811_CR44","first-page":"425","volume":"104","author":"D Shin","year":"2024","unstructured":"Shin D, Singh M, Shlofmitz E, Scheller B, Latib A, Kandzari DE, et al. Paclitaxel-coated versus sirolimus-coated balloon angioplasty for coronary artery disease: A systematic review and meta-analysis. Catheter Cardiovasc Interv. 2024;104(3):425\u201336.","journal-title":"Catheter Cardiovasc Interv"},{"key":"6811_CR45","doi-asserted-by":"publisher","first-page":"775","DOI":"10.3390\/futurepharmacol4040041","volume":"4","author":"FL Gurgoglione","year":"2024","unstructured":"Gurgoglione FL, De Gregorio M, Benatti G, Donelli D, Vignali L, Solinas E, et al. Paclitaxel-Coated Versus Sirolimus-Coated Eluting Balloons for Percutaneous Coronary Interventions: Pharmacodynamic Properties, Clinical Evidence, and Future Perspectives. Future Pharmacol. 2024;4:775\u201387.","journal-title":"Future Pharmacol"},{"key":"6811_CR46","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s11658-019-0164-y","volume":"24","author":"L Zhu","year":"2019","unstructured":"Zhu L, Chen L. Progress in research on paclitaxel and tumor immunotherapy. Cell Mol Biol Lett. 2019;24:40.","journal-title":"Cell Mol Biol Lett"},{"issue":"3 Suppl","key":"6811_CR47","doi-asserted-by":"publisher","first-page":"S7","DOI":"10.1016\/S0041-1345(03)00211-2","volume":"35","author":"SN Sehgal","year":"2003","unstructured":"Sehgal SN. Sirolimus: its discovery, biological properties, and mechanism of action. Transpl Proc. 2003;35(3 Suppl):S7\u201314.","journal-title":"Transpl Proc"},{"issue":"10","key":"6811_CR48","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1007\/s00270-018-2018-9","volume":"41","author":"U Speck","year":"2018","unstructured":"Speck U, H\u00e4ckel A, Schellenberger E, Kamann S, L\u00f6chel M, Clever YP, et al. Drug Distribution and Basic Pharmacology of Paclitaxel\/Resveratrol-Coated Balloon Catheters. Cardiovasc Intervent Radiol. 2018;41(10):1599\u2013610.","journal-title":"Cardiovasc Intervent Radiol"},{"issue":"6","key":"6811_CR49","doi-asserted-by":"publisher","first-page":"740","DOI":"10.4244\/EIJY15M10_01","volume":"12","author":"JF Granada","year":"2016","unstructured":"Granada JF, Tellez A, Baumbach WR, Bingham B, Keng YF, Wessler J, et al. In vivo delivery and long-term tissue retention of nano-encapsulated sirolimus using a novel porous balloon angioplasty system. EuroIntervention. 2016;12(6):740\u20137.","journal-title":"EuroIntervention"},{"issue":"1","key":"6811_CR50","doi-asserted-by":"publisher","first-page":"148","DOI":"10.4244\/EIJV9I1A21","volume":"9","author":"PA Lemos","year":"2013","unstructured":"Lemos PA, Farooq V, Takimura CK, Gutierrez PS, Virmani R, Kolodgie F, et al. Emerging technologies: polymer-free phospholipid encapsulated sirolimus nanocarriers for the controlled release of drug from a stent-plus-balloon or a stand-alone balloon catheter. EuroIntervention. 2013;9(1):148\u201356.","journal-title":"EuroIntervention"},{"issue":"4","key":"6811_CR51","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1097\/FJC.0b013e3180325b0a","volume":"49","author":"YW Chen","year":"2007","unstructured":"Chen YW, Smith ML, Sheets M, Ballaron S, Trevillyan JM, Burke SE, et al. Zotarolimus, a novel sirolimus analogue with potent anti-proliferative activity on coronary smooth muscle cells and reduced potential for systemic immunosuppression. J Cardiovasc Pharmacol. 2007;49(4):228\u201335.","journal-title":"J Cardiovasc Pharmacol"},{"issue":"1","key":"6811_CR52","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.ahj.2006.10.017","volume":"153","author":"M Pan","year":"2007","unstructured":"Pan M, de Lezo JS, Medina A, Romero M, Delgado A, Segura J, et al. Drug-eluting stents for the treatment of bifurcation lesions: a randomized comparison between paclitaxel and sirolimus stents. Am Heart J. 2007;153(1):15\u2013e1.","journal-title":"Am Heart J"},{"issue":"14","key":"6811_CR53","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.4244\/EIJY19M01_01","volume":"14","author":"FJ Neumann","year":"2019","unstructured":"Neumann FJ, Sousa-Uva M, Ahlsson A, Alfonso F, Banning AP, Benedetto U, et al. 2018 ESC\/EACTS Guidelines on myocardial revascularization. EuroIntervention. 2019;14(14):1435\u2013534.","journal-title":"EuroIntervention"},{"issue":"8","key":"6811_CR54","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1016\/j.jcin.2015.04.008","volume":"8","author":"A Latib","year":"2015","unstructured":"Latib A, Ruparelia N, Menozzi A, Castriota F, Micari A, Cremonesi A, et al. 3-year follow-up of the balloon elution and late loss optimization study (BELLO). JACC Cardiovasc Interv. 2015;8(8):1132\u20134.","journal-title":"JACC Cardiovasc Interv"},{"issue":"10261","key":"6811_CR55","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1016\/S0140-6736(20)32173-5","volume":"396","author":"RV Jeger","year":"2020","unstructured":"Jeger RV, Farah A, Ohlow MA, Mangner N, M\u00f6bius-Winkler S, Weilenmann D, et al. Long-term efficacy and safety of drug-coated balloons versus drug-eluting stents for small coronary artery disease (BASKET-SMALL 2): 3-year follow-up of a randomised, non-inferiority trial. Lancet. 2020;396(10261):1504\u201310.","journal-title":"Lancet"},{"issue":"10194","key":"6811_CR56","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/S0140-6736(19)31126-2","volume":"394","author":"TT Rissanen","year":"2019","unstructured":"Rissanen TT, Uskela S, Er\u00e4nen J, M\u00e4ntyl\u00e4 P, Olli A, Romppanen H, et al. Drug-coated balloon for treatment of de-novo coronary artery lesions in patients with high bleeding risk (DEBUT): a single-blind, randomised, non-inferiority trial. Lancet. 2019;394(10194):230\u20139.","journal-title":"Lancet"},{"issue":"17","key":"6811_CR57","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.4244\/EIJ-D-19-00723","volume":"15","author":"B Scheller","year":"2020","unstructured":"Scheller B, Ohlow MA, Ewen S, Kische S, Rudolph TK, Clever YP, et al. Bare metal or drug-eluting stent versus drug-coated balloon in non-ST-elevation myocardial infarction: the randomised PEPCAD NSTEMI trial. EuroIntervention. 2020;15(17):1527\u201333.","journal-title":"EuroIntervention"},{"issue":"14","key":"6811_CR58","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.4244\/EIJV15I14A220","volume":"15","author":"A Lansky","year":"2020","unstructured":"Lansky A, Cremonesi A, Scheller B, James S, Grubman D, Fajadet J, et al. Clinical outcome after interventions with paclitaxel-coated balloons: a PCR statement. EuroIntervention. 2020;15(14):1225\u20137.","journal-title":"EuroIntervention"},{"issue":"9","key":"6811_CR59","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1016\/j.jacc.2019.11.065","volume":"75","author":"B Scheller","year":"2020","unstructured":"Scheller B, Vukadinovic D, Jeger R, Rissanen TT, Scholz SS, Byrne R, et al. Survival after coronary revascularization with paclitaxel-coated balloons. J Am Coll Cardiol. 2020;75(9):1017\u201328.","journal-title":"J Am Coll Cardiol"},{"key":"6811_CR60","doi-asserted-by":"crossref","unstructured":"Rathore S. Small coronary vessel angioplasty: outcomes and technical considerations. Vasc Health Risk Manag [Internet]. 2010;915. Available from: http:\/\/www.dovepress.com\/small-coronary-vessel-angioplasty-outcomes-and-technical-consideration-peer-reviewed-article-VHRM","DOI":"10.2147\/VHRM.S8161"},{"key":"6811_CR61","doi-asserted-by":"publisher","unstructured":"Felbel D, Bozic F, Mayer B, Krohn-Grimberghe M, Paukovitsch M, D\u2019Almeida S et al. Drug-coated balloon: an effective alternative to stent strategy in small-vessel coronary artery disease\u2014a meta-analysis. Front Cardiovasc Med [Internet]. 2023;10. Available from: https:\/\/www.frontiersin.org\/articles\/https:\/\/doi.org\/10.3389\/fcvm.2023.1213992\/full","DOI":"10.3389\/fcvm.2023.1213992\/full"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-026-06811-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-026-06811-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-026-06811-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T20:02:16Z","timestamp":1792699336000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-026-06811-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,22]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["6811"],"URL":"https:\/\/doi.org\/10.1186\/s12872-026-06811-8","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,22]]},"assertion":[{"value":"24 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"965"}}